HDAC3 and plasma cell myeloma: In particular, HDAC3 has been reported to regulate c-Myc protein levels, thereby HDAC3 inhibition increased acetylation of c-Myc as well as DNMT1 in myeloma cells, leading to degradation of DNMT1 and inhibition of myeloma cell growth (54).